phosphorylcholine has been researched along with Bladder Cancer in 5 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effects of intravesical administration of paclitaxel (PTX-30W), which was prepared by solubilization with a water-soluble amphiphilic polymer composed of PMB30W, a copolymer of 2-methacryloyloxyethyl phosphorylcholine and n-butyl methacrylate, in an orthotopic bladder cancer model." | 7.81 | Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model. ( Ishihara, K; Kikuchi, E; Konno, T; Matsumoto, K; Miyajima, A; Oya, M; Tamura, K, 2015) |
| "To evaluate the effects of intravesical administration of paclitaxel (PTX-30W), which was prepared by solubilization with a water-soluble amphiphilic polymer composed of PMB30W, a copolymer of 2-methacryloyloxyethyl phosphorylcholine and n-butyl methacrylate, in an orthotopic bladder cancer model." | 3.81 | Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model. ( Ishihara, K; Kikuchi, E; Konno, T; Matsumoto, K; Miyajima, A; Oya, M; Tamura, K, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piyarathna, DWB | 1 |
| Rajendiran, TM | 1 |
| Putluri, V | 1 |
| Vantaku, V | 1 |
| Soni, T | 1 |
| von Rundstedt, FC | 1 |
| Donepudi, SR | 1 |
| Jin, F | 1 |
| Maity, S | 1 |
| Ambati, CR | 1 |
| Dong, J | 1 |
| Gödde, D | 1 |
| Roth, S | 1 |
| Störkel, S | 1 |
| Degener, S | 1 |
| Michailidis, G | 1 |
| Lerner, SP | 1 |
| Pennathur, S | 1 |
| Lotan, Y | 1 |
| Coarfa, C | 1 |
| Sreekumar, A | 1 |
| Putluri, N | 1 |
| Tamura, K | 1 |
| Kikuchi, E | 1 |
| Konno, T | 1 |
| Ishihara, K | 1 |
| Matsumoto, K | 1 |
| Miyajima, A | 1 |
| Oya, M | 1 |
| Zang, ZL | 1 |
| Liu, SQ | 1 |
| Chen, X | 1 |
| Li, YJ | 1 |
| Zhou, B | 1 |
| Xu, XH | 1 |
| Konstantinov, SM | 1 |
| Berger, MR | 1 |
| Rümenapp, U | 1 |
| Lümmen, G | 1 |
| Virchow, S | 1 |
| Hanske, J | 1 |
| Meyer zu Heringdorf, D | 1 |
| Jakobs, KH | 1 |
5 other studies available for phosphorylcholine and Bladder Cancer
| Article | Year |
|---|---|
Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder.
Topics: Carcinoma, Transitional Cell; Case-Control Studies; Chromatography, Liquid; Computational Biology; D | 2018 |
Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.
Topics: Administration, Intravesical; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Ce | 2015 |
[Synthesis and antitumor activity of selenophosphocholine analogues containing tegafur].
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Organoselenium Com | 2006 |
Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Enzyme-Li | 1999 |
Sphingolipid receptor signaling and function in human bladder carcinoma cells: inhibition of LPA- but enhancement of thrombin-stimulated cell motility.
Topics: Actins; Calcium; Carcinoma; Cell Division; Cell Movement; Cyclic AMP; GTP-Binding Proteins; Humans; | 2000 |